No Data
No Data
Express News | Mainz Biomed Shares Are Trading Higher on Possible Continued Strength After the Company Reported a Year-over-year Increase in FY24 EPS Results on Tuesday
Mainz Biomed 2024 Loss/Shr $22.36 >MYNZ
Mainz Biomed 2024 Rev $893,991 >MYNZ
Express News | Mainz Biomed FY24 EPS ($22.36) Up From ($64.76) YoY; Revenue $893.9K Down From $895.4K YoY
Mainz Biomed Reports FY24 EPS ($22.36) Vs ($64.76) Last Year
Mainz Biomed | 6-K: Report of foreign private issuer (related to financial reporting)